Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL609524 | 0.93 | LMNA (0.40) | LMNAHSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL475144 | 0.88 | TSHR (0.43) | ALDH1A1TSHRTDP1GAA | |
| SCHEMBL14245000 | 0.84 | SOAT1 (0.39) | LMNAHSD17B10ALDH1A1GAAELANE | |
| SCHEMBL27338223 | 0.84 | LMNA (0.32) | LMNAHSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL27338219 | 0.84 | LMNA (0.32) | LMNAHSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL15160841 | 0.82 | CA1 (0.41) | LMNAHSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL21433590 | 0.82 | LMNA (0.36) | LMNAHSD17B10ALDH1A1GAAELANE | |
| SCHEMBL4924852 | 0.81 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1GAAELANE | |
| SCHEMBL12411135 | 0.81 | LMNA (0.33) | LMNAHSD17B10ALDH1A1TSHRTDP1 | |
| SCHEMBL10087931 | 0.80 | ALDH1A1 (0.50) | LMNAHSD17B10ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170174994-A1 | COMPOUND AND LIQUID CRYSTAL COMPOSITION EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174994-A1 | COMPOUND AND LIQUID CRYSTAL COMPOSITION EMPLOYING THE SAME | ZYX, ZRANB2, CXXC4 | LMNA 624/4885HSD17B10 1823/4885ALDH1A1 3113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.